Citicoline, also known as CDP-choline, is an essential nutrient that plays a crucial role in maintaining brain function. It is highly valued for its ability to enhance memory, increase focus, and support overall neurological health. Despite these benefits, citicoline faces challenges in terms of bioavailability and absorption, which can reduce its effectiveness as a dietary supplement.
Benefits of Citicoline
Citicoline is a precursor to phosphatidylcholine, a vital component of brain cell membranes. It supports neuroprotection and neuroplasticity and is used to treat and prevent conditions related to cognitive decline, such as Alzheimer’s disease and acute brain damage. It also helps to improve cerebral blood flow and reduce neurological damage following strokes.
Citicoline MINIACTIVES®: An Innovative Solution by IPS
To overcome the bioavailability limits of citicoline, IPS International Products & Services S.r.l. has developed Citicoline MINIACTIVES®, utilizing advanced microencapsulation technology to enhance the release and absorption of the active ingredient. Thanks to the MINIACTIVES® particle coating system, citicoline is protected during gastric transit and released more effectively in the intestine, maximizing its beneficial effects and ensuring better biological absorption.
Studies and Scientific Collaborations
IPS is engaged in collaborations with universities and research centers to validate the efficacy and safety of its technologies. Recent studies on 3D organoid systems have shown that MINIACTIVES® technology, similar to MATRIS® technology, extends the half-life of active ingredients and significantly reduces levels of inflammation and gastric and intestinal sensitization, resulting in superior absorption compared to raw ingredients. These results underscore the importance of IPS innovations in enhancing the anti-inflammatory and antioxidant activity of active ingredients.
Formulations and Applications
Citicoline MINIACTIVES® is available for creating various dosage forms, such as tablets, sachets, stick packs, capsules, and vials. For applications that require direct compression, IPS also offers SmarTTabs®, which preserve the original active release profile of the bulk product, ensuring the integrity and efficacy of the active ingredient.
Conclusion
Citicoline MINIACTIVES® by IPS represents a significant advancement in the nutraceutical supplement field, offering an effective solution to overcome traditional challenges associated with the use of citicoline. IPS’s commitment to research and innovation continues to redefine quality standards in the nutraceutical industry, improving the health and well-being of patients with cutting-edge and scientifically validated products.
Note: This article is provided for informational purposes only and does not substitute for professional medical advice.
